Every now and then scientists come out with different research results or studies explaining us what is healthy for us, what is not, what we should or shouldn’t do. It is not so rare that it happens that one year something is a health booster and in few years it becomes almost like a poison.
How often do you reach for herbal supplements during day, week, month, year..? While considering it as doing a favor to your health or immune system, turning it into a substitute for the healthy diet you still haven’t started with. Or when was the last time you didn’t feel comfortable with taking a generic drug, or just had no idea what it really meant? And when was the last time you felt like you have committed a crime after eating frozen pizza? Or is it just FDA having double standards when it comes to some things? Let’s start from the beginning.
AstraZeneca PLC, the global pharmaceutical giant and the UK’s second biggest drug company, informed that it planned to restructure itself by introducing downsizing program and reorganizing its global research and development operations. The main idea of the strategy, which is to substantially help the company, is to slash approximately 1,600 jobs in the next three years.
Valeant Pharmaceuticals International Inc. informed that it would acquire buy Medicis Pharmaceutical Corp. for $2.6 billion in cash. The deal will add Botox competitor Dysport and other skin care drugs to the company’s portfolio. Valeant, the largest publicly traded drug maker in Canada, intends to expand its dermatological products. In addition, the acquisition of Medicis is a part of the Valeant’s acquisition strategy which slipped on last year’s bid for Cephalon Inc.
Many reasons have been cited for these 2011 drug shortages. A recent study from the IMS Institute found that health manufacturing problems, discontinuations and suspension of production, inability to meet demand, raw material problems, and contamination or other quality issues are particularly relevant. Business decisions by manufacturers and industry leaders, often involving profitability, also play a key role in shortages, and this issue extends beyond the low return on investment of generics.
Bye-bye Vasectomies (and if women can have it their way, bye-bye oral contraceptive pills too) ! This wonder drug, which has been developed at the Indian Institute of Technology in Kharagpur, India, promises to be a much safer, easier and reversible contraceptive method for men, and has garnered widespread global interest. As opposed to a vasectomy, […]
In what could possibly be a breakthrough in the process of whole-body imaging, researchers at the Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein, which has been dubbed iRFP, that enables scientists to clearly “see” the internal organs of living animals without the need for a scalpel or imaging […]
With a never-before seen strain of E. Coli having reportedly affected 1600 people across Europe, scientists are calling the new bug super-toxic. And while primary suspicion for transmission of this bug has been laid on raw tomatoes, cucumbers and lettuce, experts have been unable to identify for sure the source of the E. coli, which […]
British American Tobacco (BAT), estimated to be the world’s second largest tobacco group by global market share, has confirmed reports of having established Nicoventures Limited, a start-up company that aims to commercialize sans-tobacco nicotine products which could help wean smokers off its cigarettes. A bold move you think ? Sure – in terms of creating […]